Clinical Trials for Electroacupuncture Combined With Paclitaxel Protein-bound and PD-1 Antibody for Second-line Treatment of HER2 Negative, pMMR/MSS Advanced Gastric Cancer
Find clinical trials for electroacupuncture combined with paclitaxel protein-bound and pd-1 antibody for second-line treatment of her2 negative, pmmr/mss advanced gastric cancer. Discover research opportunities and treatment options in your area.
No Active Trials Found
There are currently no active clinical trials for electroacupuncture combined with paclitaxel protein-bound and pd-1 antibody for second-line treatment of her2 negative, pmmr/mss advanced gastric cancer in our database.
Condition: Electroacupuncture Combined With Paclitaxel Protein-bound and PD-1 Antibody for Second-line Treatment of HER2 Negative, pMMR/MSS Advanced Gastric Cancer